Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (50)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Laporte, J.
Right arrow Articles by Bertini, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Laporte, J.
Right arrow Articles by Bertini, E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Molecular Genetics, Vol 6, 1505-1511, Copyright © 1997 by Oxford University Press


ARTICLES

Mutations in the MTM1 gene implicated in X-linked myotubular myopathy. ENMC International Consortium on Myotubular Myopathy. European Neuro- Muscular Center

J Laporte, C Guiraud-Chaumeil, MC Vincent, JL Mandel, SM Tanner, S Liechti- Gallati, C Wallgren-Pettersson, N Dahl, W Kress, PA Bolhuis, M Fardeau, F Samson and E Bertini
IGBMC, CNRS/INSERM/ULP, Illkirch, France.

X-linked recessive myotubular myopathy (XLMTM) is characterized by severe hypotonia and generalized muscle weakness, with impaired maturation of muscle fibres. The gene responsible, MTM1, was identified recently by positional cloning, and encodes a protein (myotubularin) with a tyrosine phosphatase domain (PTP). Myotubularin is highly conserved through evolution and defines a new family of putative tyrosine phosphatases in man. We report the identification of MTM1 mutations in 55 of 85 independent patients screened by single-strand conformation polymorphism for all the coding sequence. Large deletions were observed in only three patients. Five point mutations were found in multiple unrelated patients, accounting for 27% of the observed mutations. The possibility of detecting mutations and determining carrier status in a disease with a high proportion of sporadic cases is of importance for genetic counselling. More than half of XLMTM mutations are expected to inactivate the putative enzymatic activity of myotubularin, either by truncation or by missense mutations affecting the predicted PTP domain. Additional mutations are missenses clustered in two regions of the protein. Most of these affect amino acids conserved in the homologous yeast and Caenorhabditis elegans proteins, thus indicating the presence of other functional domains.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
N. Kalfa, B. Liu, K. Ophir, F. Audran, M.-H. Wang, C. Mei, C. Sultan, and L. S Baskin
Mutations of CXorf6 are associated with a range of severities of hypospadias
Eur. J. Endocrinol., October 1, 2008; 159(4): 453 - 458.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
V. Tosch, H. M. Rohde, H. Tronchere, E. Zanoteli, N. Monroy, C. Kretz, N. Dondaine, B. Payrastre, J.-L. Mandel, and J. Laporte
A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy
Hum. Mol. Genet., November 1, 2006; 15(21): 3098 - 3106.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Tsujita, T. Itoh, T. Ijuin, A. Yamamoto, A. Shisheva, J. Laporte, and T. Takenawa
Myotubularin Regulates the Function of the Late Endosome through the GRAM Domain-Phosphatidylinositol 3,5-Bisphosphate Interaction
J. Biol. Chem., April 2, 2004; 279(14): 13817 - 13824.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Xue, H. Fares, B. Grant, Z. Li, A. M. Rose, S. G. Clark, and E. Y. Skolnik
Genetic Analysis of the Myotubularin Family of Phosphatases in Caenorhabditis elegans
J. Biol. Chem., September 5, 2003; 278(36): 34380 - 34386.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
I. J. Sutton, J. B. Winer, A. N. Norman, S. Liechti-Gallati, and F. MacDonald
Limb girdle and facial weakness in female carriers of X-linked myotubular myopathy mutations
Neurology, September 11, 2001; 57(5): 900 - 902.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. S. Taylor, T. Maehama, and J. E. Dixon
Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate
PNAS, July 12, 2000; (2000) 160255697.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
K. North
NEW PERSPECTIVES IN PEDIATRIC NEUROMUSCULAR DISORDERS Hotel Intercontinental Sydney, Sydney, Australia, August 28, 1998
J Child Neurol, January 1, 1999; 14(1): 26 - 57.
[PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
G. S. Taylor, T. Maehama, and J. E. Dixon
Inaugural Article: Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate
PNAS, August 1, 2000; 97(16): 8910 - 8915.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.